Suboptimal Selenium Intake Produces Sex-Specific Alterations in Metabolic Profiles in Western Diet-Fed Obese Mice
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27125345 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Sarah K Walsh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Obesity Research and Education (CORE), School of Pharmacy, Applied Sciences and Public Health, Robert Gordon University, Aberdeen AB10 7GJ…. Hauptthemen laut MEDLINE: Selenium, Diet, Western, Obesity, Metabolome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Friends of ANCHOR, Centre for Obesity Research and Education (CORE), School of Pharmacy, Applied Sciences and Public Health, Robert Gordon University, Aberdeen, United Kingdom.
Abstract (Originalsprache)
Selenium (Se) is an essential micronutrient required for redox regulation and metabolic homeostasis. Altered biomarkers of Se status have been linked with obesity and metabolic syndrome, yet its role in these conditions, particularly in a sex-specific context, is not well defined. This study investigated the impact of suboptimal Se intake on metabolic risk profiles in male and female mice with pre-existing diet-induced obesity. C57BL/6N mice were fed either a standard diet with adequate Se (SD-ASe), a Western diet with adequate Se (WD-ASe), or WD-ASe followed by a Western diet containing suboptimal Se levels (WD-SOSe). Metabolic parameters, adipokine profiles, tissue Se distribution, and gene expression in visceral white adipose tissue (vWAT) were assessed. Both sexes exhibited increased weight gain and adiposity in response to a Western diet; however, only males developed hypertension and elevated non-fasted blood glucose levels. Suboptimal Se intake elicited marked sex-dependent effects. In females, it induced elevated non-fasted blood glucose levels and circulating leptin, and further dysregulated circulating adipokine profiles, accompanied by pronounced alterations in selenoprotein expression and redox-related pathways in vWAT. In contrast, male mice exhibited a partial adaptation, including reduced glucose levels and minimal alterations in gene expression. Tissue Se distribution also appeared to be influenced by biological sex. These findings demonstrate that suboptimal Se intake may exacerbate obesity-related metabolic dysfunction in a sex-specific manner, with females showing greater susceptibility, underscoring the importance of micronutrient status and sex differences in metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Obesity Research and Education (CORE), School of Pharmacy, Applied Sciences and Public Health, Robert Gordon University, Aberdeen AB10 7GJ, UK.
ORCID-Profile: Isabella Mezzani, Giovanna Bermano
Förderung
- Friends of ANCHOR
- Centre for Obesity Research and Education (CORE), School of Pharmacy, Applied Sciences and Public Health, Robert Gordon University, Aberdeen, United Kingdom
Zitieren
APA
Walsh, S. K., Mezzani, I., Pettigrew, K., Hesketh, J. E., & Bermano, G. (2026). Suboptimal Selenium Intake Produces Sex-Specific Alterations in Metabolic Profiles in Western Diet-Fed Obese Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27125345
Vancouver
Walsh SK, Mezzani I, Pettigrew K, Hesketh JE, Bermano G. Suboptimal Selenium Intake Produces Sex-Specific Alterations in Metabolic Profiles in Western Diet-Fed Obese Mice. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27125345
BibTeX
@article{Walsh2026,
author = {Walsh, Sarah K and Mezzani, Isabella and Pettigrew, Katy and Hesketh, John E and Bermano, Giovanna},
title = {Suboptimal Selenium Intake Produces Sex-Specific Alterations in Metabolic Profiles in Western Diet-Fed Obese Mice},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27125345}
}
EUVIMED